Hyperprolactinaemia in males: A heterogeneous disorder

Australian and New Zealand Journal of Medicine

Volumn 27, Issue 4, 1997, Pages 385-390

  Walsh, J P ^a   Pullan, P T ^b  

^a HUDSON INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b SIR CHARLES GAIRDNER HOSPITAL   (Australia)

Author keywords

Bromocriptine; Hypogonadism; Pituitary tumour; Prolactin; Prolactinoma

Indexed keywords

BROMOCRIPTINE;

ADULT; AGED; ARTICLE; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DIPLOPIA; GALACTORRHEA; GYNECOMASTIA; HEADACHE; HUMAN; HYPERPROLACTINEMIA; HYPOGONADISM; HYPOPHYSIS TUMOR; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PROLACTINOMA; VISUAL IMPAIRMENT;

EID: 0030826258     PISSN: 00048291     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1445-5994.1997.tb02196.x     Document Type: Article

References (21)

1. Thorner MO, Vance ML, Horvath E, Kovacs K. The anterior pituitary. In: Wilson JD, Foster DW (Eds.). Williams textbook of endocrinology-, 8th ed. Philadelphia: W B Saunders, 1992; 221-310.
2. Molitch M. Prolactinoma. In: Melmed S (Ed.). The pituitary. Cambridge, Massachusetts: Blackwell Science, 1995; 443-77.
3. Levy A, Lightman SL. Diagnosis and management of pituitary tumours. BrMedJ 1994; 308: 1087-91.
4. Nabarro J D N. Pituitary prolactinomas. Clin Endocrinol 1982; 17: 129-55.
5. Dupuy M, Derome PJ, Peillon F et al. L'adénome à prolactine chez l'homme. Etude pré- et post-opératoire de quatre-vingts cas. Sem Hop Par 1984; 60: 2943-54.
6. Carter JN, Tyson JE, Tous G, Van Vliet S, Faiman C, Friesen HG. Prolactin-secreting tumors and hypogonadism in 22 men. N Engl J Med 1978; 299: 847-52.
7. Hulling A-L, Muhr C, Lundberg PO, Werner S. Prolactinomas in men: clinical characteristics and the effect of bromocriptine treatment. Acta Med Scand 1985; 217: 101-9.
8. Camanni F, Ciccarelli E. Prolactinomas. In: Grossman A (Ed.). Clinical endocrinology. Oxford: Blackwell Scientific Publications, 1992; 132-47.
9. Goodman RH, Molitch ME, Post KD, Jackson IMD. Prolactin-secreting adenomas in the male. In: Post KD, Jackson IDM, Reichlin S (Eds.). The pituitary adenoma. New York: Plenum, 1980; 91-108.
10. Grisoli F, Vincentelli F, Jacquet P, Guibout M, Hassoun J, Farnarier P. Prolactin secreting adenoma in 22 men. Surg Neurol 1980; 13: 241-7.
11. Berezin M, Shimon I, Hadani M. Prolactinoma in 53 men: clinical characteristics and modes of treatment (male prolactinoma). J Endocrinol Invest 1995; 18: 436-41.
12. Somma M, Beauregard H, Rasio E. Le prolactinome chez l'homme. Evaluation préopératoire de 40 patients. Neurochirurgie 1981; 27 Suppl. 1: 37-9.
13. Franks S, Jacobs HS, Martin N, Nabarro JDN. Hyperprolactinaemia and impotence. Clin Endocrinol 1978; 8: 277-87.
14. Pressman BD. Pituitary imaging. In: Melmed S (Ed.). The pituitary. Cambridge, Massachusetts: Blackwell Science, 1995; 663-86.
15. Nagulesparen M, Ang V, Jenkins JS. Bromocriptine treatment of males with pituitary tumours, hyperprolactinaemia, and hypogonadism. Clin Endocrinol 1978;9:73-9.
16. Pontiroli AE, Falsetti L. Development of pituitary adenoma in women with hyperprolactinaemia: clinical, endocrine and radiological characteristics. Br Med J 1984; 288: 515-8.
17. Martin TL, Kirn M, Malarkey JVB. The natural history of idiopathic hyperprolactinemia. J Clin Endocrinol Metab 1985; 60:855-8.
18. Schlechte J, Dolan K, Sherman B, Chapter F, Luciano A. The natural history of untreated hyperprolactinemia: a prospective analysis. J Clin Endocrinol Metab 1989; 68: 412-8.
19. Prescott RWG, Johnston DG, Kendall-Taylor P et al. Hyperprolactinaemia in men -response to bromocriptine therapy. Lancet 1982; i: 245-9.
20. Vance AIL, Evans JVS, Thorner MO. Bromocriptine. Ann Intern Med 1984; 100:78-91.
21. Molitch ME, Elton RL, Blackwell RE et a!. Bromocriptine as primary therapy for prolactin-secreting macroadenornas: results of a prospective multicentre study. J Clin Endocrinol Metab 1985; 60: 698-705.